Cargando…
Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
Osteosarcoma (OS) is a malignant tumor prevalent in adolescents; however, a clinically effective treatment for this malignancy is lacking. The lack of effective treatment methods and factors, such as recurrence and drug resistance, further dampen the prospect of clinically treating OS. In recent yea...
Autores principales: | Tang, Zhaopeng, Lu, Yubao, Chen, Yutong, Zhang, Jiarui, Chen, Zhijun, Wang, Qianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326994/ https://www.ncbi.nlm.nih.gov/pubmed/34323141 http://dx.doi.org/10.1177/15330338211034262 |
Ejemplares similares
-
MicroRNA-1236-3p inhibits human osteosarcoma growth
por: Li, Jiarui, et al.
Publicado: (2020) -
Research Progress of Exosome-Loaded miRNA in Osteosarcoma
por: Yao, Peng, et al.
Publicado: (2022) -
Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma
por: Golbakhsh, Mohammad Reza, et al.
Publicado: (2016) -
MicroRNA Involvement in Osteosarcoma
por: Kobayashi, Eisuke, et al.
Publicado: (2012) -
Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis
por: Lu, Dejie, et al.
Publicado: (2022)